Jan 21, 2025 · Australian contract development and manufacturing organizations (CDMOs), BioCina and NovaCina, have merged in a move to pool their biologic and small molecule production expertise and infrastructure. BioCina, which specializes in process development and manufacturing for microbial, plasmid DNA, and ...

Oct 8, 2024 · But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any impacts on future business? The Biosecure Act was first proposed by the US government late last year due to concerns about national security and how genetic and other biological data could be misused by foreign adversarial governments with a focus on China.

Nov 6, 2024 · Tim Davis, vice president of strategy at Veeva eCOA, had a conversation with Outsourcing Pharma's senior editor, Liza Laws, and sheds light on how the landscape is changing and what this means for study teams, sites, and overall trial efficiency.

Dec 3, 2024 · The pharmaceutical business unit of the German giant Körber has snapped up the compatriot label and leaflet supplier Wilhelm Bähren GmbH & Co as the pharmaceutical packaging market is set to double in the coming decade.

Jan 30, 2025 · Daily news on pharmaceutical outsourcing. Free access to news on pharmaceutical supply, pharmaceutical manufacturing, contract research and pharmaceutical services

Jan 16, 2025 · The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical methodologies. Regulatory agencies are pushing for trials that better integrate patient needs, fostering more effective and inclusive treatments. Companies like One2Treat are ...

Apr 8, 2024 · Clinicians in Scotland can now administer dostarlimab in conjunction with platinum-containing chemotherapy for adult patients diagnosed with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer, who are suitable candidates for systemic therapy.

Aug 29, 2024 · The $680 million transaction, announced on August 26, involves the sale of established brands such as Keppra, Vimpat, Neupro, Zyrtec, and Xyzal, along with UCB's Zhuhai manufacturing site, to CBC Group and Mubadala Investment Company.

Vetter is a leading global contract development and manufacturing organization (CDMO) for the aseptic production of injectables. Our headquarters are in Ravensburg, Germany, where we have been a family-owned company since our start as a pharmacy in 1950.

Dec 4, 2008 · Final guidance on the cooperative manufacture of licensed biologics has been issued by the FDA, which gives companies an outline of how to share responsibilities through the production process.